Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

ZOLL Launches the First Pediatric Electrodes That Report CPR Quality



  ZOLL Launches the First Pediatric Electrodes That Report CPR Quality

  Pediatric Solution Provides Optimal Support for Resuscitation of Children

Business Wire

CHELMSFORD, Mass. -- December 12, 2012

ZOLL^® Medical Corporation, a manufacturer of medical devices and related
software solutions, announced today that its new FDA-cleared OneStep™
Pediatric CPR Electrodes are the only electrodes on the market with a built-in
sensor that reports CPR quality on young children up to 8 years of age. This
first-of-its-kind electrode provides optimal support for pediatric
resuscitation when paired with the ZOLL R Series^® Monitor/Defibrillator and
its CPR Dashboard^™.

The R Series offers the most extensive pediatric capabilities available in a
professional defibrillator with smart, simple, and safe pediatric support. The
OneStep CPR Pediatric Electrodes can be used for monitoring, pacing, and
defibrillation, as well as CPR.

“Too often, clinicians who treat children need to compromise and adapt devices
designed for adults because there isn’t a pediatric version available,” said
Jonathan Rennert, President of ZOLL. “We recognize that the needs of children
are different from adults and have provided a range of capabilities to support
the special needs of the youngest patients.”

With the vast majority of pediatric arrests due to respiratory failure, the
importance of high-quality CPR cannot be minimized. The 2010 American Heart
Association Guidelines place a heavy emphasis on good-quality CPR. Without a
built-in CPR sensor, it’s difficult to judge how hard clinicians are pushing
when performing CPR on a child. The FDA-cleared CPR Dashboard for the R Series
reports the actual depth and rate of compressions delivered. A CPR timer
gauges the CPR periods for optimal ventilation, while a metronome is activated
if the rate falls below 100 compressions per minute. CPR data can be reviewed
after the code and used for quality improvements.

In addition, ZOLL’s See-Thru CPR^®, a proprietary filter that allows
clinicians to see if an organized rhythm is developing during CPR, is also
active with the pediatric CPR pads. See-Thru CPR helps to reduce the duration
of interruptions to CPR and speeds time to shock when indicated.

In the event of a cardiac arrest, as soon as the pediatric electrodes are
placed on the patient, the R Series immediately adjusts its AED analysis
algorithm to pediatric parameters in order to reduce the likelihood that a
compensating rhythm will be terminated. This ensures that any unique pediatric
ECG morphology will be accurately identified when a shock is indicated.

The R Series is designed with a focus on simplicity to minimize errors and
confusion. When the pediatric electrodes are attached to the R Series, the
shock energy is automatically lowered to a starting dose of 50 joules. The R
Series then measures the actual patient impedance and adjusts accordingly,
delivering sufficient current for effective conversion while not delivering
inaccurate energy to the child. The R Series can be configured to
automatically lower the setting to whatever dose is desired, even as low as
one joule.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets
medical devices and software solutions that help advance emergency care and
save lives, while increasing clinical and operational efficiencies. With
products for defibrillation and monitoring, circulation and CPR feedback, data
management, fluid resuscitation, and therapeutic temperature management, ZOLL
provides a comprehensive set of technologies that help clinicians, EMS and
fire professionals, and lay rescuers treat victims needing resuscitation and
critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding
company Asahi Kasei Corp., with operations in the chemicals and fibers, homes
and construction materials, electronics, and health care business sectors. Its
health care operations include devices and systems for critical care,
dialysis, therapeutic apheresis, transfusion, and manufacture of
biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and
nutritional products. With more than 25,000 employees around the world, the
Asahi Kasei Group serves customers in more than 100 countries. For more
information, visit www.asahi-kasei.co.jp/asahi/en/.

Copyright © 2012 ZOLL Medical Corporation. All rights reserved. CPR Dashboard,
OneStep, R Series, See-Thru CPR, and ZOLL are trademarks and/or registered
trademarks of ZOLL Medical Corporation in the United States and/or other
countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation.
All trademarks are the property of their respective owners.

Contact:

ZOLL Medical Corporation
Diane Egan, +1-978-421-9637
degan@zoll.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement